GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » 3-Year Revenue Growth Rate

Big Pharma Split (TSX:PRM) 3-Year Revenue Growth Rate : -24.30% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split 3-Year Revenue Growth Rate?

Big Pharma Split's Revenue per Share for the six months ended in Dec. 2023 was C$0.36.

During the past 12 months, Big Pharma Split's average Revenue per Share Growth Rate was -89.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was -24.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -31.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Big Pharma Split was 25.50% per year. The lowest was -24.30% per year. And the median was -5.75% per year.


Competitive Comparison of Big Pharma Split's 3-Year Revenue Growth Rate

For the Asset Management subindustry, Big Pharma Split's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Big Pharma Split's 3-Year Revenue Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's 3-Year Revenue Growth Rate falls into.



Big Pharma Split 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Big Pharma Split  (TSX:PRM) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Big Pharma Split 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Big Pharma Split (TSX:PRM) Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Executives
Michael Kovacs Director, Senior Officer